Page 11 - Ayurvedic Sciences News Today

Industry > Industry monitor > Healthcare 29 April 2021 Ayush 64, a poly-herbal preparation originally developed by the Central Council for Research in Ayurvedic Sciences (CCRAS) for the treatment of Malaria, in the year 1980 and now repurposed for the treatment Covid-19, has been found to be useful in the treatment of asymptomatic, mild and moderate Covid-19 infection as an adjunct to standard care. Ministry of Ayush and the Council of Scientific and Industrial Research (CSIR) recently collabor...

What Message Does the Government Promoting AYUSH 64 Today Send? 10/05/2021 A bottle of AYUSH 64 tablets. Image: Amazon.in On April 29, the Union Ministry of AYUSH1announced that AYUSH 64, “a poly-herbal formulation developed by the Central Council for Research in Ayurvedic Sciences (CCRAS),” could help meaningfully treat “asymptomatic, mild and moderate COVID-19 infections as an adjunct to standard care”. Standard care, technically ‘standard of care’, according to the US ...

Indigenous herbal medicines helpful in treating mild to moderate Covid ​ By Hitesh Tikoo ( IANS) | Published on ​ Sat, May 8 2021 12:36 IST | ​ 3 Views   Can alternative medicine systems like Ayurveda be tapped to fight Covid-19?.(photo:India Narrative). Image Source: IANS News New Delhi, May 8 : Two indigenous herbal medicines have been found useful in the treatment of mild to moderate Covid-19 infection, the Ministry of AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeop...

Ayush Ministry launches distribution of AYUSH 64, Kabasura Kudineer ​ By IANS | Published on ​ Fri, May 7 2021 19:36 IST | ​ 4 Views Ayush Ministry launches distribution of AYUSH 64, Kabasura Kudineer. Image Source: IANS News New Delhi, May 7 : The Ministry of Ayush on Friday launched a massive nationwide campaign to distribute its poly herbal ayurvedic drugs AYUSH 64 and Kabasura Kudineer to the majority of out of hospital Covid patients. In a statement the Ministry claimed that the...

Ayush Ministry launches nationwide distribution campaign of herbal medicines Multiple studies have been conducted on AYUSH-64, an Ayurvedic formulation developed by the Central Council for Research in Ayurvedic Sciences (CCRAS), and Kabasura Kudineer, a classical Siddha formulation BusinessToday.In | May 7, 2021 | Updated 17:55 IST The Ministry has stated that the efficacy of these drugs has been proven through robust multi-centre clinical trials Ministry of Ayush on Friday announced that it i...

NEW DELHI: The Ayush ministry on Friday said it has launched a massive nationwide campaign to distribute its proven poly herbal ayurvedic drug AYUSH 64 and Sidha medicine Kabasura Kudineer for the benefit of Covid patients in home isolation. The efficacy of these drugs has been proved through robust multi-centre clinical trials, the ministry said in its statement. AYUSH-64 is recommended in National Clinical Management Protocol based on ayurveda and yoga which is vetted by National Task Force...

All about AYUSH-64, polyherbal drug found useful in treating mild to moderate COVID cases AYUSH-64 can be useful for the treatment of asymptomatic, mild and moderate COVID-19 infection cases, the Ministry of AYUSH said. Share Updated: May 3, 2021, 08:08 PM IST AYUSH-64, a drug developed for curing malaria in 1980, can be useful for the treatment of asymptomatic, mild and moderate COVID-19 infection cases, the Ministry of AYUSH said on Thursday. Central Council for Research in Ayurvedic Sciences...

Antiviral drug Clevira repurposed for treatment of mild to moderate COVID-19 cases Photo: Pexels Clevira, a drug primarily developed to treat dengue, has been repurposed as supportive treatment for mild to moderate COVID-19 cases, its manufacturer Apex Laboratories Private Limited said on Friday. The drug is effective when taken orally and the dosage is one tablet twice daily after food for 14 days. The drug has also proved to be safe on liver and kidney parameters, it said. "Clevira, an antivi...

India News: NEW DELHI: Clevira, a drug primarily developed to treat dengue, has been repurposed as supportive treatment for mild to moderate Covid-19 cases, its m.

New Delhi: Clevira, a drug primarily developed to treat dengue, has been repurposed as a supportive treatment for mild to moderate COVID-19 cases, its